<SEC-DOCUMENT>0000785161-22-000003.txt : 20220125
<SEC-HEADER>0000785161-22-000003.hdr.sgml : 20220125
<ACCEPTANCE-DATETIME>20220125171042
ACCESSION NUMBER:		0000785161-22-000003
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20220124
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220125
DATE AS OF CHANGE:		20220125

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Encompass Health Corp
		CENTRAL INDEX KEY:			0000785161
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HOSPITALS [8060]
		IRS NUMBER:				630860407
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10315
		FILM NUMBER:		22554717

	BUSINESS ADDRESS:	
		STREET 1:		9001 LIBERTY PARKWAY
		CITY:			BIRMINGHAM
		STATE:			AL
		ZIP:			35242
		BUSINESS PHONE:		205-967-7116

	MAIL ADDRESS:	
		STREET 1:		9001 LIBERTY PARKWAY
		CITY:			BIRMINGHAM
		STATE:			AL
		ZIP:			35242

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHSOUTH CORP
		DATE OF NAME CHANGE:	19950113

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHSOUTH REHABILITATION CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ehc-20220124.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:9183fd02-6ba0-427e-aed8-2afb8feef5c2,g:4e4b24bf-85db-4e7c-8d21-1420c27e3951,d:117dd72c894846f7948aebad942a54fd--><html xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>ehc-20220124</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF80L2ZyYWc6MWM0NjAyYzFhZmJlNDgzNDgzNTk5YjAyNWI1M2IyZmEvdGFibGU6NDJlYTFjYjBjZmIzNDQzZTgxNGE0NTYzMzUwYzUxNTYvdGFibGVyYW5nZTo0MmVhMWNiMGNmYjM0NDNlODE0YTQ1NjMzNTBjNTE1Nl8wLTEtMS0xLTkwODQw_1049c634-9f10-41ba-b5f3-8b6c676f5646">false</ix:nonNumeric><ix:nonNumeric contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF80L2ZyYWc6MWM0NjAyYzFhZmJlNDgzNDgzNTk5YjAyNWI1M2IyZmEvdGFibGU6NDJlYTFjYjBjZmIzNDQzZTgxNGE0NTYzMzUwYzUxNTYvdGFibGVyYW5nZTo0MmVhMWNiMGNmYjM0NDNlODE0YTQ1NjMzNTBjNTE1Nl8xLTEtMS0xLTkwODQw_b7856ed8-ea9d-4ad2-939e-939bec232984">0000785161</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="ehc-20220124.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000785161</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-24</xbrli:startDate><xbrli:endDate>2022-01-24</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i117dd72c894846f7948aebad942a54fd_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:10pt"><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGV4dHJlZ2lvbjpkNjk3NGMwOGM2NzE0YjE2YjI5OGEzZmE2MmY0MjFhYl8xMjY5_87a180c8-9a77-4510-8ce0-438d8c70fafc">8-K</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (date of earliest event reported): <ix:nonNumeric contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGV4dHJlZ2lvbjpkNjk3NGMwOGM2NzE0YjE2YjI5OGEzZmE2MmY0MjFhYl8yMjU_7b34d820-4cd2-4794-a7a4-8d342db3637c">January 24, 2022</ix:nonNumeric> </span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:28pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGV4dHJlZ2lvbjpkNjk3NGMwOGM2NzE0YjE2YjI5OGEzZmE2MmY0MjFhYl8xMjcw_c285b0a4-dc7b-4943-8c2e-72cd89276fbd">Encompass Health Corporation</ix:nonNumeric> </span></div><div style="margin-top:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of Registrant as specified in its Charter)</span></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGV4dHJlZ2lvbjpkNjk3NGMwOGM2NzE0YjE2YjI5OGEzZmE2MmY0MjFhYl8xMjYy_376ca7a9-7bc8-437e-9c04-1b06c19240b8">Delaware</ix:nonNumeric> </span></div><div style="margin-top:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(State or Other Jurisdiction of Incorporation)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGFibGU6Y2E1MGNiOTllNDY1NGE2YWIzMTI2Zjc0ZGU5NTA0MDYvdGFibGVyYW5nZTpjYTUwY2I5OWU0NjU0YTZhYjMxMjZmNzRkZTk1MDQwNl8wLTAtMS0xLTkwODQw_f92f4f4d-04b5-4bc0-95fb-ceed39c207a9">001-10315</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGFibGU6Y2E1MGNiOTllNDY1NGE2YWIzMTI2Zjc0ZGU5NTA0MDYvdGFibGVyYW5nZTpjYTUwY2I5OWU0NjU0YTZhYjMxMjZmNzRkZTk1MDQwNl8wLTEtMS0xLTkwODQw_bf2a08a6-3441-4aeb-84b6-dea2823b213b">63-0860407</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(IRS Employer Identification No.)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGV4dHJlZ2lvbjpkNjk3NGMwOGM2NzE0YjE2YjI5OGEzZmE2MmY0MjFhYl8xMjYz_4834072c-09c8-4b25-b935-b77d27091091">9001 Liberty Parkway</ix:nonNumeric>, <ix:nonNumeric contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGV4dHJlZ2lvbjpkNjk3NGMwOGM2NzE0YjE2YjI5OGEzZmE2MmY0MjFhYl8xMjY0_14199743-68c2-446e-aeea-e262afc8394d">Birmingham</ix:nonNumeric>, <ix:nonNumeric contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGV4dHJlZ2lvbjpkNjk3NGMwOGM2NzE0YjE2YjI5OGEzZmE2MmY0MjFhYl8xMjY1_c379699f-4607-46c9-bdb7-7b240f6450bf">Alabama</ix:nonNumeric> <ix:nonNumeric contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGV4dHJlZ2lvbjpkNjk3NGMwOGM2NzE0YjE2YjI5OGEzZmE2MmY0MjFhYl8xMjY2_b17fb179-daea-4f44-8311-96371c305377">35242</ix:nonNumeric></span></div><div style="margin-top:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices, Including Zip Code)</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">(<ix:nonNumeric contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGV4dHJlZ2lvbjpkNjk3NGMwOGM2NzE0YjE2YjI5OGEzZmE2MmY0MjFhYl8xMjYx_ea0ff63c-45a9-4a27-825f-c8f537fbf8fe">205</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGV4dHJlZ2lvbjpkNjk3NGMwOGM2NzE0YjE2YjI5OGEzZmE2MmY0MjFhYl8xMjY3_7cb1dd31-30ef-4be2-af07-05dded433c34">967-7116</ix:nonNumeric> </span></div><div style="margin-top:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:6.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.716%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGFibGU6OGUyNWIwOGEzMjRkNGNmZDk4OTk4YjNmNThhZTE3N2MvdGFibGVyYW5nZTo4ZTI1YjA4YTMyNGQ0Y2ZkOTg5OThiM2Y1OGFlMTc3Y18wLTAtMS0xLTkwODQw_213f5900-577b-4a87-a3dd-3964d5b441c1">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGFibGU6OGUyNWIwOGEzMjRkNGNmZDk4OTk4YjNmNThhZTE3N2MvdGFibGVyYW5nZTo4ZTI1YjA4YTMyNGQ0Y2ZkOTg5OThiM2Y1OGFlMTc3Y18yLTAtMS0xLTkwODQw_42bea57f-c82d-4c08-8e69-a436ee5b1f9b">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGFibGU6OGUyNWIwOGEzMjRkNGNmZDk4OTk4YjNmNThhZTE3N2MvdGFibGVyYW5nZTo4ZTI1YjA4YTMyNGQ0Y2ZkOTg5OThiM2Y1OGFlMTc3Y180LTAtMS0xLTkwODQw_ec40354d-8e94-43c5-9c1b-a4e9a12fce49">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGFibGU6OGUyNWIwOGEzMjRkNGNmZDk4OTk4YjNmNThhZTE3N2MvdGFibGVyYW5nZTo4ZTI1YjA4YTMyNGQ0Y2ZkOTg5OThiM2Y1OGFlMTc3Y182LTAtMS0xLTkwODQw_844919c4-baa3-401f-91ee-4f47fd6df5dc">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div></td></tr></table></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. &#160;&#160;&#160;&#160;Emerging growth company&#160;&#160;      <ix:nonNumeric contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGV4dHJlZ2lvbjpkNjk3NGMwOGM2NzE0YjE2YjI5OGEzZmE2MmY0MjFhYl8xMjY4_def96faa-9f21-4021-be1b-100847cbeeaa">&#9744;</ix:nonNumeric> </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange    Act. &#9744;</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.713%"><tr><td style="width:1.0%"></td><td style="width:37.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.739%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGFibGU6YTc5NzRmMGFkZmE2NDQzOWE3OTAxOWE3NWUzMzJkYzIvdGFibGVyYW5nZTphNzk3NGYwYWRmYTY0NDM5YTc5MDE5YTc1ZTMzMmRjMl8xLTAtMS0xLTkwODQw_06b607d7-cf65-4207-bfbe-d38663a8fe94">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGFibGU6YTc5NzRmMGFkZmE2NDQzOWE3OTAxOWE3NWUzMzJkYzIvdGFibGVyYW5nZTphNzk3NGYwYWRmYTY0NDM5YTc5MDE5YTc1ZTMzMmRjMl8xLTEtMS0xLTkwODQw_de61cfdb-4743-4091-8a33-2cfa7878c348">EHC</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGFibGU6YTc5NzRmMGFkZmE2NDQzOWE3OTAxOWE3NWUzMzJkYzIvdGFibGVyYW5nZTphNzk3NGYwYWRmYTY0NDM5YTc5MDE5YTc1ZTMzMmRjMl8xLTItMS0xLTkwODQw_a4e94e3b-cd9d-465f-b930-89389ac01f5c">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><span><br/></span></div></div></div><div id="i117dd72c894846f7948aebad942a54fd_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:10pt"><span><br/></span></div></div><div style="margin-bottom:10pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1.01.&#160;</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Entry into a Material Definitive Agreement.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 25, 2022, Encompass Health Corporation (the &#8220;Company&#8221;) announced the expiration on January 24, 2022 of its solicitation of consents (the &#8220;Consent Solicitation&#8221;) from the holders of its 4.50% Senior Notes due 2028 (the &#8220;2028 Notes&#8221;), 4.75% Senior Notes due 2030 (the &#8220;2030 Notes&#8221;) and 4.625% Senior Notes due 2031 (the &#8220;2031 Notes&#8221; and, together with the 2028 Notes and the 2030 Notes, the &#8220;Notes&#8221;) having received the requisite consents for the adoption of certain amendments to each Existing Indenture (defined below) governing the Notes. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 24, 2022, the Company and certain of its subsidiaries entered into the Twelfth Supplemental Indenture (the &#8220;Twelfth Supplemental Indenture&#8221;) to amend the previously executed Indenture, dated as of December 1, 2009 (the &#8220;Base Indenture&#8221;), between the Company and Wells Fargo Bank, National Association, as successor to The Bank of Nova Scotia Trust Company of New York, as trustee (the &#8220;Trustee&#8221;), as previously supplemented by (i) with respect to the 2028 Notes, the Eighth Supplemental Indenture, dated September 18, 2019 (the &#8220;Eighth Supplemental Indenture,&#8221;), (ii) with respect to the 2030 Notes, the Ninth Supplemental Indenture, dated September 18, 2019 (the &#8220;Ninth Supplemental Indenture&#8221;) and (iii) with respect to the 2031 Notes, the Tenth Supplemental Indenture, dated October 5, 2020 (the &#8220;Tenth Supplemental Indenture&#8221;), in each case, among the Company, the subsidiary guarantors named therein, and the Trustee.  The Base Indenture, together with, as applicable in the case of the relevant series of Notes, the Eighth Supplemental Indenture, the Ninth Supplemental Indenture or the Tenth Supplemental Indenture, as applicable, is referred to herein as an &#8220;Existing Indenture,&#8221; and each Existing Indenture as supplemented by the Twelfth Supplemental Indenture is referred to herein as an &#8220;Indenture&#8221;.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Each Existing Indenture contains restrictive covenants that, among other things, limit the Company&#8217;s ability and the ability of certain of its subsidiaries to make certain asset dispositions, investments, and distributions to holders of the Company&#8217;s capital stock. The amendments to the Existing Indentures permit, subject to the leverage ratio condition set forth below, the Company to distribute to the Company&#8217;s equity holders in one or more transactions (a &#8220;Distribution&#8221;) some or all of the common stock of a subsidiary that holds substantially all of the assets of the Company&#8217;s home health and hospice business. The Company may make any such distribution so long as the Leverage Ratio (as defined in each Indenture) is no more than 3.5 to 1.0 on a pro forma basis after giving effect thereto. The amendments also reduce the capacity under the Company&#8217;s restricted payments builder basket under each Existing Indenture by $200 million. Additionally, the Twelfth Supplemental Indenture amends the definition of &#8220;Consolidated Net Income&#8221; to allow the Company to exclude from Consolidated Net Income (a component of the Leverage Ratio) any fees, expenses or charges related to any Distribution and the solicitation of consents from the holders of the Notes and the holders of the Company&#8217;s 5.750% Senior Notes due 2025. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The descriptions of the provisions of the Base Indenture, the Eighth Supplemental Indenture, the Ninth Supplemental Indenture, the Tenth Supplemental Indenture and the Twelfth Supplemental Indenture are summary in nature and are qualified in their entirety by reference to the provisions of the definitive agreements. The Base Indenture was filed as an exhibit to the Company&#8217;s Annual Report on Form 10&#8209;K for the year ended December 31, 2009 and is incorporated herein by reference. The Eighth Supplemental Indenture, which includes the form of the 2028 Notes, was filed on September 18, 2019 as Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K and is incorporated herein by reference. The Ninth Supplemental Indenture, which includes the form of the 2030 Notes, was filed on September 18, 2019 as Exhibit 4.3 to the Company&#8217;s Current Report on Form 8-K and is incorporated herein by reference. The Tenth Supplemental Indenture, which includes the form of the 2031 Notes, was filed on October 5, 2020 as Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K and is incorporated herein by reference. The Twelfth Supplemental Indenture is attached hereto as Exhibit 4.5 and is incorporated herein by reference.</span></div><div style="padding-left:54pt;text-indent:-54pt"><span><br/></span></div><div id="i117dd72c894846f7948aebad942a54fd_10"></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3.03. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Material Modification to Rights of Security Holders. </span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information included in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference. </span></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-54pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><span><br/></span></div></div></div><div id="i117dd72c894846f7948aebad942a54fd_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:10pt"><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Statements and Exhibits.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Exhibits</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:16.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.855%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/785161/000078516110000011/exhibit_4-7110k.htm">4.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/785161/000078516110000011/exhibit_4-7110k.htm">Indenture, dated as of December 1, 2009, by and between the Company and the Trustee (incorporated herein by reference to Exhibit 4.7.1 to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2009).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000785161/000119312519247756/d760186dex42.htm">4.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000785161/000119312519247756/d760186dex42.htm">Eighth Supplemental Indenture, dated as of September 18, 2019, by and among the Company, the Guarantors and the Trustee </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000785161/000119312519247756/d760186dex42.htm">relating to the 4.500% Notes due 2028)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000785161/000119312519247756/d760186dex42.htm">(incorporated herein by reference to Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K filed on </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000785161/000119312519247756/d760186dex42.htm">September 18, 2019</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000785161/000119312519247756/d760186dex42.htm">).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000785161/000119312519247756/d760186dex43.htm">4.3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000785161/000119312519247756/d760186dex43.htm">Ninth Supplemental Indenture, dated as of September 18, 2019, by and among the Company, the Guarantors and the Trustee (relating to the 4.750% Notes due 2030) (incorporated herein by reference to Exhibit 4.3 to the Company&#8217;s Current Report on Form 8-K filed on September 18, 2019). </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000785161/000119312520263689/d12659dex42.htm">4.4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000785161/000119312520263689/d12659dex42.htm">Tenth Supplemental Indenture, dated as of October 5, 2020, by and among the Company, the Guarantors and the Trustee (relating to the 4.625% Notes due 2031) (incorporated herein by reference to Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K filed on October 5, 2020). </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="twelfthsupplementalindeture.htm">4.5</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="twelfthsupplementalindeture.htm">Twelfth Supplemental Indenture, dated as of January 24, 2022, by and among the Company, the subsidiary guarantors named therein and the Trustee (relating to the 4.500% Notes due 2028, 4.750% Notes due 2030 and 4.625% Notes due 2031).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File - the cover page iXBRL tags are embedded within the Inline XBRL document.</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><span><br/></span></div></div></div><div id="i117dd72c894846f7948aebad942a54fd_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:10pt"><span><br/></span></div></div><div style="margin-bottom:10pt"><span><br/></span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:10pt;padding-left:144pt;text-align:right;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.701%"><tr><td style="width:1.0%"></td><td style="width:7.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.448%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.691%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ENCOMPASS HEALTH CORPORATION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160;&#160; Patrick Darby</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patrick Darby</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, General Counsel and Secretary</span></td></tr></table></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated: January 25, 2022</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.5
<SEQUENCE>2
<FILENAME>twelfthsupplementalindeture.htm
<DESCRIPTION>EX-4.5
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i3690ae8cd69747be84944aa2f50dc96c_1"></div><div style="min-height:77.76pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit 4.5 </font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EXECUTION VERSION</font></div></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">TWELFTH SUPPLEMENTAL INDENTURE </font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ENCOMPASS HEALTH CORPORATION </font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WELLS FARGO BANK, NATIONAL ASSOCIATION,</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as Trustee</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Dated as of January 24, 2022</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><font><br></font></div></td></tr></table></div></div></div><div id="i3690ae8cd69747be84944aa2f50dc96c_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.228%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:right;vertical-align:bottom">Page</td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.37pt;padding-right:1.37pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE I</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">DEFINITIONS</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.01.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Definitions</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE II</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">AMENDMENT OF EACH EXISTING INDENTURE</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.01.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Amendment of Section 5.06 of each Existing Indenture</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.02.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Amendment of Article I of each Existing Indenture</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.03.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Amendment of Article VI of each Existing Indenture</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.04.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Amendment of Article XVI of each Existing Indenture</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE III</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EFFECTIVENESS</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.01.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Effectiveness of Supplemental Indenture</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE IV</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLES TO BE READ TOGETHER</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 4.01.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Instruments To Be Read Together</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 4.02.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Parties</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE V</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">MISCELLANEOUS</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.01.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Integral Part</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.02.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Adoption, Ratification and Confirmation</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.03.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Counterparts</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.04.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Severability</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.05.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Governing Law</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.06.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Trustee Makes No Representation</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.07.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Damages Limitation</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.08.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">U.S.A. PATRIOT Act</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-ii-</font></div></div></div><div id="i3690ae8cd69747be84944aa2f50dc96c_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">TWELFTH SUPPLEMENTAL INDENTURE dated as of January 24, 2022 (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">Supplemental Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221;), between ENCOMPASS HEALTH CORPORATION, a Delaware corporation (formerly known as HealthSouth Corporation, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221;), the subsidiaries of the Company party hereto (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">Subsidiary Guarantors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221;) and WELLS FARGO BANK, NATIONAL ASSOCIATION, as trustee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">Trustee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">W I T N E S S E T H&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">WHEREAS the Company has heretofore entered into a senior indenture, dated as of December 1, 2009 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">Base Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221;), with the Trustee, as amended, supplemented or otherwise modified prior to the date hereof, including by that certain (i) Eighth Supplemental Indenture, dated as of September 18, 2019 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">Eighth Supplemental Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221;), providing for the issuance of the Company&#8217;s 4.500% Senior Notes due 2028 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">2028 Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221;), (ii) Ninth Supplemental Indenture, dated as of September 18, 2019 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">Ninth Supplemental Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221;), providing for the issuance of the Company&#8217;s 4.750% Senior Notes due 2030 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">2030 Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221;), and (iii) Tenth Supplemental Indenture, dated as of October 5, 2020 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">Tenth Supplemental Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221; and together with the Eighth Supplemental Indenture and Ninth Supplemental Indenture, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">Existing Supplemental Indentures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221;), providing for the issuance of the Company&#8217;s 4.625% Senior Notes due 2031 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">2031 Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221;, and, together with the 2028 Securities and the 2030 Securities, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221;). The Base Indenture, together with, as applicable in the case of the relevant series of Securities, the Eighth Supplemental Indenture, the Ninth Supplemental Indenture or the Tenth Supplemental Indenture, as applicable, is referred to herein as an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">Existing Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221;&#894;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">WHEREAS, the Company expects to effect the partial or full separation of its home health and hospice business (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">HH&#38;H Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221;).  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">WHEREAS, in connection with a potential spin-off or other distribution of at least 80.1% of the capital stock of the HH&#38;H Business to the Company&#8217;s stockholders, in each case which distribution has not been preceded by an IPO or other public listing of the capital stock of the HH&#38;H Business), the Company, pursuant to the Consent Solicitation Statement dated  December 9, 2021, as modified by the Company&#8217;s Supplement to Consent Solicitation Statement Dated December 9, 2021 dated January 18, 2022 and as further modified prior to the date hereof (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">Consent Solicitation Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221;), solicited and received consents from Holders of each series of Securities representing a majority in aggregate principal amount of each such series of Securities, allowing it to amend the applicable Existing Indenture as described herein&#59; </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">WHEREAS, the Company has received the consent of the Holders of each series of Securities of at least a majority in principal amount of the outstanding Securities of such series (excluding any Securities owned by the Company or any of its Affiliates), all as certified by a certificate of the information agent with respect to the Consent Solicitation, as the duly appointed proxy of such Holders, delivered to the Company and the Trustee, the Company has delivered to the Trustee simultaneously with the execution and delivery of this Supplemental Indenture an Officers&#8217; Certificate and an Opinion of Counsel relating to this Supplemental Indenture pursuant to each Existing Indenture, and the Company has satisfied all other conditions required under each Existing Indenture to enable the Company, the Subsidiary Guarantors, and the Trustee to enter into this Supplemental Indenture&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:6pt"><font><br></font></div></div><div><font><br></font></div><div style="margin-bottom:0.12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">WHEREAS, pursuant to Section 14.02 of each Existing Indenture, the Company, the Subsidiary Guarantors and the Trustee are authorized to execute and deliver this Supplemental Indenture to effectuate the Amendments (as defined below)&#59;</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">WHEREAS all conditions necessary to authorize the execution and delivery of this Supplemental Indenture and to make it a valid and binding obligation of the Company and the Subsidiary Guarantors have been done or performed&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">NOW, THEREFORE, in consideration of the agreements and obligations set forth herein and for other good and valuable consideration, the sufficiency of which is hereby acknowledged, the parties hereto hereby agree as follows&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:110%"><br></font></div><div style="padding-right:-18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:110%">ARTICLE I</font></div><div style="padding-right:-18pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:110%">DEFINITIONS</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">SECTION 1.01.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;padding-left:30.36pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">.  Section 1.01 of each Existing Indenture is hereby amended by adding the following definition therein in correct alphabetical order.</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">Consent Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221;, in respect of each series of Securities, has the meaning set forth in the Consent Solicitation Statement.</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">Consent Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221; has the meaning set forth in the Consent Solicitation Statement. </font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">Consent Solicitation Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221; means the Company&#8217;s Consent Solicitation Statement dated December 9, 2021, as modified by the Company&#8217;s Supplement to Consent Solicitation Statement Dated December 9, 2021 dated January 18, 2022 and as further modified prior to January 24, 2022.</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">Distribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221; means the distribution to equityholders of the Company, whether in respect of Company Capital Stock or in exchange for Company Capital Stock, of at least 80.1% of the common stock of SpinCo (with cash in lieu of any fractional shares) in one or more transactions.</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">Operative Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221; means the date on which the Company makes the Second Consent Payment. </font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">Permitted Retained Interest Disposition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221; means any disposition (including in exchange for the Capital Stock or Indebtedness of the Company) of all or a portion of the Retained Interest in one or more transactions.</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">Required Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221; has the meaning set forth in the Consent Solicitation Statement.</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">Retained Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221; means any Capital Stock of SpinCo held by the Company from time to time after any Distribution. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-2-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:6pt"><font><br></font></div></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">Second Consent Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221; has the meaning set forth in the Consent Solicitation Statement. </font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">SpinCo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221; means an existing or newly formed corporation holding substantially all of the assets of the Company&#8217;s home health and hospice business.</font></div><div style="padding-left:72pt"><font><br></font></div><div style="margin-bottom:9pt;padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:110%">ARTICLE II</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:110%">AMENDMENT OF EACH EXISTING INDENTURE</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">SECTION 2.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;padding-left:33.36pt;text-decoration:underline">Amendment of Section 5.06 of each Existing Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">.  From and after the Operative Date (as defined below), clause (a) of the second paragraph of Section 5.06 of each Existing Supplemental Indenture  (Release of Subsidiary Guarantor) with respect to each series of Securities is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">(a) upon the designation (other than in accordance with clause (2) of the definition of &#8220;Unrestricted Subsidiary&#8221;) of such Subsidiary Guarantor as an Unrestricted Subsidiary in accordance with the terms of the Indenture&#59;</font></div><div style="margin-bottom:9pt;text-align:justify"><font><br></font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">SECTION 2.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;padding-left:33.36pt;text-decoration:underline">Amendment of Article I of each Existing Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">.  From and after the Operative Date, Section 1.01 of each Existing Indenture with respect to each series of Securities is hereby amended by making the following stricken and underlined changes (unaffected clauses are not reproduced here)</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">(a) the definition of &#8220;Asset Disposition&#8221; in each Existing Indenture is hereby amended as follows&#58; </font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">(J) a disposition of cash or Temporary Cash Investments&#894; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline line-through">and</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">(K) the creation of a Lien (but not the sale or other disposition of the property subject to such Lien)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline line-through">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">&#59;</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">(L) any Distribution, so long as the Leverage Ratio is no more than 3.5 to 1.0 on a pro forma basis after giving effect thereto&#59; and</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">(M) any Permitted Retained Interest Disposition, so long as the Leverage Ratio is no more than 3.5 to 1.0 on a pro forma basis after giving effect thereto.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">(b) the definition of &#8220;Consolidated Net Income&#8221; in each Existing Indenture is hereby amended as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">(6) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">extraordinary gains or losses&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:line-through"> and</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">(7) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">the cumulative effect of a change in accounting principles</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:line-through">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">&#59; and</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">(8) solely in connection with determining whether the making of any Distribution or any Permitted Retained Interest Disposition is permitted hereunder (including for purposes of Section 16.12), any fees, expenses or charges related to the Consent Solicitation (including the Consent Payment), any Distribution or any Permitted Retained Interest Disposition,</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-3-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:6pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify"><font><br></font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">(c) the definition of &#8220;Permitted Investments&#8221; in each Existing Indenture is hereby amended as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">(14) a Receivables Entity, or any Investment by a Receivables Entity in any other Person in connection with a Qualified Receivables Transaction, including Investments of funds held in accounts permitted or required by the arrangements governing such Qualified Receivables Transaction or any related Indebtedness&#894; provided, however, that any Investment in a Receivables Entity is in the form of a purchase money note, contribution of additional receivables or an equity interest&#894; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline line-through">or</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">(15) Persons to the extent such Investments, when taken together with all other Investments made pursuant to this clause (15) and outstanding on the date such Investment is made, do not exceed 10% of Consolidated Tangible Assets, as determined based on the consolidated balance sheet of the Company as of the end of the most recent fiscal quarter ending at least 45 days prior thereto</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:line-through">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">&#59;</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">(16) Investments in the Retained Interest&#59; and</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">(17) any Investment in SpinCo and its Subsidiaries on the Operative Date in connection with their designation as Unrestricted Subsidiaries hereunder in accordance with the definition of &#8220;Unrestricted Subsidiary&#8221;.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">(d) the definition of &#8220;Unrestricted Subsidiary&#8221; in each Existing Indenture is hereby amended in its entirety to read as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">Unrestricted Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221; means&#58;</font><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">(1) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">any Subsidiary of the Company that at the time of determination shall be designated an Unrestricted Subsidiary by the Board of Directors in the manner provided below&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline line-through">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">(2) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">on and after the Operative Date (automatically and without any action taken by the Company), SpinCo&#59; and</font><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">(</font><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:line-through">2</font><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">3</font><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">any Subsidiary of an Unrestricted Subsidiary.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">SECTION 2.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;padding-left:33.36pt;text-decoration:underline">Amendment of Article VI of each Existing Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">.  From and after the Operative Date (as defined below), Section 6.04 of each Existing Indenture (Limitation on Restricted Payments) with respect to each series of Securities is hereby amended by making the following stricken and underlined changes (unaffected subsections are not reproduced here)&#58;</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">(a) Section 6.04(a) in each Existing Indenture (Limitation on Restricted Payments) is hereby amended as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">(3) the aggregate amount of such Restricted Payment and all other Restricted Payments since the Issue Date would exceed the sum of (without duplication)&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">(A) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">50% of the Consolidated Net Income accrued during the period (treated as one accounting period) from and including July 1, 2006 to the end of the most recent fiscal quarter ending at least 45 days prior to the date of such Restricted Payment (or, in case such Consolidated Net Income shall be a deficit, minus 100% of such deficit)&#59; plus</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-4-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:6pt"><font><br></font></div></div><div style="padding-left:72pt"><font><br></font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">(B) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">100% of the aggregate Net Cash Proceeds received by the Company from the issuance or sale of its Capital Stock (other than Disqualified Stock) subsequent to the Issue Date (other than an issuance or sale to a Subsidiary of the Company and other than an issuance or sale to an employee stock ownership plan or to a trust established by the Company or any of its Subsidiaries for the benefit of their employees) and 100% of any cash capital contribution received by the Company from its shareholders subsequent to the Issue Date&#59; plus</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">(C) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">the amount by which Indebtedness of the Company is reduced on the Company&#8217;s balance sheet upon the conversion or exchange subsequent to the Issue Date of any Indebtedness of the Company convertible or exchangeable for Capital Stock (other than Disqualified Stock) of the Company (less the amount of any cash, or the fair value of any other property, distributed by the Company upon such conversion or exchange)&#59; provided, however, that the foregoing amount shall not exceed the Net Cash Proceeds received by the Company or any Restricted Subsidiary from the sale of such Indebtedness (excluding Net Cash Proceeds from sales to a Subsidiary of the Company or to an employee stock ownership plan or to a trust established by the Company or any of its Subsidiaries for the benefit of their employees)&#59; plus</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">(D) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">an amount equal to the net reduction in the Investments (other than Permitted Investments) made by the Company or any Restricted Subsidiary in any Person resulting from repurchases, repayments or redemptions of such Investments by such Person, proceeds realized on the sale of such Investment and proceeds representing the return of capital (excluding dividends and distributions), in each case received by the Company or any Restricted Subsidiary&#59; provided, however, that the foregoing sum shall not exceed, in the case of any such Person, the amount of Investments (excluding Permitted Investments) previously made (and treated as a Restricted Payment) by the Company or any Restricted Subsidiary in such Person&#59; plus</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">(E) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">in the case of the redesignation of an Unrestricted Subsidiary as a Restricted Subsidiary, the portion (proportionate to the Company&#8217;s equity interest in such Subsidiary) of the Fair Market Value of the net assets of such Unrestricted Subsidiary at the time such Unrestricted Subsidiary is redesignated as a Restricted Subsidiary, except to the extent that the Investment in such Unrestricted Subsidiary was made by the Company or a Restricted Subsidiary pursuant to Section 6.04(b)(11) or to the extent that such Investment constituted a Permitted Investment&#59; plus</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">(F) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">$50,000,000</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:line-through">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">&#59; minus</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">(G) $200,000,000.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%"> </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">(b) Section 6.04(b) in each Existing Indenture (Limitation on Restricted Payments) is hereby amended as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">(11) Restricted Payments in an amount that, when taken together with all Restricted Payments made pursuant to this clause (11), does not exceed the greater of (A) $200,000,000 and (B) 5.0% of Consolidated Tangible Assets, as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-5-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:6pt"><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">determined based on the consolidated balance sheet of the Company as of the end of the most recent fiscal quarter ending at least 45 days prior thereto&#59; provided, however, that (I) at the time of each such Restricted Payment, no Default shall have occurred and be continuing (or result therefrom) and (II) such payments shall be excluded from the calculation of the amount of Restricted Payments&#894;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline line-through"> or</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">(12) any purchase or other acquisition or retirement for value of shares of Capital Stock of Encompass Health Home Health Holdings, Inc. (f&#47;k&#47;a HealthSouth Home Health Holdings, Inc.) held by any Person other than the Company or any of its Subsidiaries on the Issue Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:line-through">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">&#59;</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">(13) any Distribution, so long as the Leverage Ratio is no more than 3.5 to 1.0 on a pro forma basis after giving effect to such Restricted Payment&#59; provided, however, that such Restricted Payment shall be excluded from the calculation of the amount of Restricted Payments&#59; or</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">(14) any Permitted Retained Interest Disposition, so long as the Leverage Ratio is no more than 3.5 to 1.0 on a pro forma basis after giving effect to such Restricted Payment&#59; provided, however, that such Restricted Payment shall be excluded from the calculation of the amount of Restricted Payments.</font></div><div style="margin-bottom:9pt"><font><br></font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">SECTION 2.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;padding-left:33.36pt;text-decoration:underline">Amendment of Article XVI of each Existing Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">.  From and after the Operative Date, Article XVI of each Existing Indenture with respect to each series of Securities is hereby amended by adding the following provision regarding the Distributions and Permitted Retained Interest Dispositions as new Section 16.12 of each Existing Indenture&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">16.12 Distributions and Permitted Retained Interest Dispositions. Notwithstanding anything to the contrary set forth in this Indenture or any supplemental indenture, no provision of this Indenture or in any supplemental indenture shall prevent the consummation of any Distribution or any Permitted Retained Interest Disposition, nor shall any Distribution or any Permitted Retained Interest Disposition give rise to any default&#59; provided, however, that in each case, the Leverage Ratio is no more than 3.5 to 1.0 on a pro forma basis after giving effect to such Distribution or Permitted Retained Interest Disposition, as applicable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">.</font></div><div style="margin-bottom:9pt;padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:110%"><br>ARTICLE III</font></div><div style="margin-bottom:9pt;padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:110%">EFFECTIVENESS</font></div><div style="margin-bottom:9pt;text-align:center"><font><br></font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">SECTION 3.01.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;padding-left:30.36pt;text-decoration:underline">Effectiveness of Supplemental Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">.  This Supplemental Indenture shall become effective on and as of the date on which the Company makes the First Consent Payment (as defined in the Consent Solicitation Statement) to Holders of each such series of Securities that are entitled to receive the First Consent Payment (as defined in the Consent Solicitation Statement) in accordance with the terms of the Consent Solicitation Statement. The amendments set forth in Article 2 hereof (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">&#8221;) shall become operative with respect to  each series of Securities on the Operative Date in respect of each such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-6-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:6pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">series of Securities.  The Company shall provide prompt written notice to the Trustee if the Second Consent Payment (as defined in the Consent Solicitation Statement) has been made and the Operative Date has occurred, or if for any reason the Second Consent Payment (as defined in the Consent Solicitation Statement) shall not be made and the Operative Date shall not occur. </font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:110%"><br>ARTICLE IV</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:110%">ARTICLES TO BE READ TOGETHER</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">SECTION 4.01.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;padding-left:30.36pt;text-decoration:underline">Instruments To Be Read Together</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">.  This Supplemental Indenture is executed as and shall constitute an indenture supplemental to and in implementation of each Existing Indenture, and each Existing Indenture and this Supplemental Indenture shall henceforth be read together.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">SECTION 4.02.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;padding-left:30.36pt;text-decoration:underline">Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">.  Nothing expressed or mentioned herein is intended or shall be construed to give any Person, firm or corporation, other than the Holders and the Trustee, any legal or equitable right, remedy or claim under or in respect of this Supplemental Indenture or any Existing Indenture or any provision herein or that therein contained.</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:110%"><br>ARTICLE V</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:18pt;padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:110%">MISCELLANEOUS</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">SECTION 5.01.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;padding-left:30.36pt;text-decoration:underline">Integral Part</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">.  This Supplemental Indenture constitutes an integral part of each Existing Indenture.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">SECTION 5.02.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;padding-left:30.36pt;text-decoration:underline">Adoption, Ratification and Confirmation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">.  Each Existing Indenture, as supplemented and amended by this Supplemental Indenture, is in all respects hereby adopted, ratified and confirmed.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">SECTION 5.03.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;padding-left:30.36pt;text-decoration:underline">Counterparts&#59; Electronic Signatures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">.  This Supplemental Indenture may be executed in any number of counterparts, each of which will be an original, but such counterparts will together constitute but one and the same Supplemental Indenture. The exchange of copies of this Supplemental Indenture and of signature pages by facsimile, .pdf transmission, email or other electronic means shall constitute effective execution and delivery of this Supplemental Indenture for all purposes. Signatures of the parties hereto transmitted by facsimile, .pdf transmission, email or other electronic means shall be deemed to be their original signatures for all purposes. This Supplemental Indenture shall be valid, binding, and enforceable against a party only when executed and delivered by an authorized individual on behalf of the party by means of (i) any electronic signature permitted by the federal Electronic Signatures in Global and National Commerce Act, state enactments of the Uniform Electronic Transactions Act, and&#47;or any other relevant electronic signatures law, including relevant provisions of the Uniform Commercial Code&#47;UCC (collectively, &#8220;Signature Law&#8221;)&#59; (ii) an original manual signature&#59; or (iii) a faxed, scanned, or photocopied manual signature. Each electronic signature or faxed, scanned, or photocopied manual signature shall for all purposes have the same validity, legal effect, and admissibility in evidence as an original manual signature. Each party hereto shall be entitled to conclusively rely upon, and shall have no liability with respect to, any faxed, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-7-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:6pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">scanned, or photocopied manual signature, or other electronic signature, of any party and shall have no duty to investigate, confirm or otherwise verify the validity or authenticity thereof. This Supplemental Indenture may be executed in any number of counterparts, each of which shall be deemed to be an original, but such counterparts shall, together, constitute one and the same instrument. For avoidance of doubt, original manual signatures shall be used for execution or indorsement of writings when required under the UCC or other Signature Law due to the character or intended character of the writings.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">SECTION 5.04.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;padding-left:30.36pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">.  Should any provision of this Supplemental Indenture for any reason be declared invalid or unenforceable, such decision shall not affect the validity or enforceability of any of the other provisions of this Supplemental Indenture, which other provisions shall remain in full force and effect and the application of such invalid or unenforceable provision to persons or circumstances other than those as to which it is held invalid or unenforceable shall be valid and be enforced to the fullest extent permitted by law.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">SECTION 5.05.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;padding-left:30.36pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">.  THIS SUPPLEMENTAL INDENTURE AND EACH SERIES OF SECURITIES SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">SECTION 5.06.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;padding-left:30.36pt;text-decoration:underline">Trustee Makes No Representation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">.  The Trustee makes no representation and shall not be responsible or accountable as to the validity, execution by the other parties hereto or sufficiency of this Supplemental Indenture or with respect to the Consent Solicitation Statement, the Consent Solicitation or the consents of Holders of any series of Securities, all of which recitals are made solely by the Company and the Guarantors, and the Trustee assumes no responsibility for the same.  The recitals and statements herein are deemed to be those of the Company and Subsidiary Guarantors and not of the Trustee and the Trustee shall not be held responsible in any manner whatsoever for their correctness.  The Trustee assumes no responsibility for the accuracy or completeness of the information concerning the Company or its Affiliates or any other Person contained in the Consent Solicitation Statement or any related documents or for any failure by the Company or any other Person to disclose events that may have occurred and may affect the significance or accuracy of such information.  </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">SECTION 5.07.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;padding-left:30.36pt;text-decoration:underline">Damages Limitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">.  In no event shall the Trustee be responsible or liable for any special, indirect, punitive or consequential loss or damage of any kind whatsoever (including, but not limited to, loss of profit), irrespective of whether the Trustee has been advised of the likelihood of such loss or damage and regardless of the form of action.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">SECTION 5.08.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;padding-left:30.36pt;text-decoration:underline">U.S.A. PATRIOT Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">.  The Company and the Subsidiary Guarantors acknowledge that in accordance with Section 326 of the U.S.A. PATRIOT Act, the Trustee, like all financial institutions and in order to help fight the funding of terrorism and money laundering, is required to obtain, verify, and record information that identifies each person or legal entity that establishes a relationship or opens an account with the Trustee.  The parties to this Supplemental Indenture agree that they shall provide the Trustee with such information as it may request in order for the Trustee to satisfy the requirements of the U.S.A. PATRIOT Act.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-8-</font></div></div></div><div id="i3690ae8cd69747be84944aa2f50dc96c_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">IN WITNESS WHEREOF, the parties hereto have executed this Supplemental Indenture on the date first set forth above.</font></div><div style="margin-bottom:24pt;padding-left:279.35pt;text-indent:-27.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">ENCOMPASS HEALTH CORPORATION, as Issuer</font></div><div style="margin-bottom:24pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">&#47;s&#47; Douglas E. Coltharp&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%"><br>Name&#58;&#160;&#160;&#160;&#160;Douglas E. Coltharp<br>Title&#58;&#160;&#160;&#160;&#160;Executive Vice President and Chief &#160;&#160;&#160;&#160;Financial Officer</font></div><div style="margin-bottom:12pt;padding-left:257.95pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br>&#91;Signature Page to Supplemental Indenture&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;padding-left:121.7pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">SUBSIDIARY GUARANTORS</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Advanced Homecare Holdings, Inc.</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Advanced Homecare Management, Inc.</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">AHM Texas LP, Inc.</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Camellia Medical Systems, Inc. </font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">CareSouth Health System, Inc.</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Continental Rehabilitation Hospital of Arizona, Inc. </font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">DOSIK, INC.</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">EHHI Holdings, Inc.</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Encompass Health C Corp Sub Holdings, Inc. </font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Encompass Health Central Arkansas Holdings, Inc. </font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Encompass Health Home Health Corporation </font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Encompass Health Home Health Holdings, Inc.</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Encompass Health Jonesboro Holdings, Inc.</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Encompass Health Rehabilitation Hospital of City View, Inc. </font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Encompass Health Rehabilitation Hospital of Colorado Springs, Inc. </font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Encompass Health Rehabilitation Hospital of Columbia, Inc.</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Encompass Health Rehabilitation Hospital of Concord, Inc. </font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Encompass Health Rehabilitation Hospital of Dothan, Inc. </font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Encompass Health Rehabilitation Hospital of Florence, Inc. </font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Encompass Health Rehabilitation Hospital of Manati, Inc. </font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Encompass Health Rehabilitation Hospital of Montgomery, Inc. </font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Encompass Health Rehabilitation Hospital of Nittany Valley, Inc. </font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Encompass Health Rehabilitation Hospital of Panama City, Inc. </font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Encompass Health Rehabilitation Hospital of San Antonio, Inc. </font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Encompass Health Rehabilitation Hospital of San Juan, Inc.</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Encompass Health Rehabilitation Hospital of Spring Hill, Inc. </font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Encompass Health Rehabilitation Hospital of Texarkana, Inc. </font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Encompass Health Rehabilitation Hospital of The Woodlands, Inc. </font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Encompass Health Rehabilitation Hospital of Treasure Coast, Inc. </font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Encompass Health Tyler Holdings, Inc.</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Encompass Health Yuma Holdings, Inc. </font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">EXCELLA HEALTHCARE, INC. </font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">EXCELLA HOMECARE, INC.</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Guardian Home Care, Inc.</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">HealthSouth Rehabilitation Hospital of Austin, Inc.</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Home Health Care of Bogalusa, Inc.</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Home Health Care Systems, Inc. </font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Idaho Homecare Holdings, Inc. </font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Reliant Blocker Corp.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Signature Page to Supplemental Indenture&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">WellCare, Inc.</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Wellmark Healthcare Services of El Paso, Inc. </font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">West Mississippi Home Health Services, Inc.</font></div><div style="margin-bottom:24pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Western Neuro Care, Inc.</font></div><div style="margin-bottom:24pt;padding-left:121.5pt;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:24pt;padding-left:121.5pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">&#47;s&#47; Edmund M. Fay&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%"><br>Name&#58;&#160;&#160;&#160;&#160;Edmund M. Fay Title&#58;&#160;&#160;&#160;&#160;Authorized Signatory</font></div><div style="margin-bottom:24pt;padding-left:121.5pt;text-indent:-18pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Signature Page to Supplemental Indenture&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Abba Home Health, L.P.</font></div><div style="padding-left:121.5pt;text-indent:-27.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">By&#58;&#160;&#160;&#160;&#160;AHM Texas GP, LLC, its General Partner</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">AHM Action Home Health, LP</font></div><div style="padding-left:121.5pt;text-indent:-27.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">By&#58;&#160;&#160;&#160;&#160;AHM Texas GP, LLC, its General Partner</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Best Home Care LP</font></div><div style="padding-left:121.5pt;text-indent:-27.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">By&#58;&#160;&#160;&#160;&#160;AHM Texas GP, LLC, its General Partner</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">DRC Health Systems, L.P.</font></div><div style="padding-left:121.5pt;text-indent:-27.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">By&#58;&#160;&#160;&#160;&#160;AHM Texas GP, LLC, its General Partner</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Encompass Health Rehabilitation Hospital of Northwest Tucson, L.P. </font></div><div style="padding-left:121.5pt;text-indent:-27.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">By&#58;&#160;&#160;&#160;&#160;Continental Rehabilitation Hospital of Arizona, Inc., its General Partner</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Encompass Health Rehabilitation Hospital of Tustin, L.P.</font></div><div style="padding-left:121.5pt;text-indent:-27.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">By&#58;&#160;&#160;&#160;&#160;Western Neuro Care, Inc., its Managing General Partner</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">EH of Fort Worth, LP, formerly known as Encompass of Fort Worth, LP</font></div><div style="padding-left:121.5pt;text-indent:-27.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">By&#58;&#160;&#160;&#160;&#160;AHM Texas GP, LLC, its General Partner</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">EH of West Texas, LP formerly known as Encompass of West Texas, LP</font></div><div style="padding-left:121.5pt;text-indent:-27.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">By&#58;&#160;&#160;&#160;&#160;AHM Texas GP, LLC, its General Partner</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Hallmark Homecare, L.P.</font></div><div style="padding-left:121.5pt;text-indent:-27.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">By&#58;&#160;&#160;&#160;&#160;AHM Texas GP, LLC, its General Partner</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Preferred Home Health, L.P.</font></div><div style="padding-left:121.5pt;text-indent:-27.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">By&#58;&#160;&#160;&#160;&#160;AHM Texas GP, LLC, its General Partner</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Texas Senior Care, L.P.</font></div><div style="margin-bottom:12pt;padding-left:121.5pt;text-indent:-27.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">By&#58;&#160;&#160;&#160;&#160;AHM Texas GP, LLC, its General Partner</font></div><div style="margin-bottom:12pt;padding-left:121.5pt;text-indent:-27.35pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:121.5pt;text-indent:-27.35pt"><font><br></font></div><div style="margin-bottom:24pt;padding-left:121.5pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%;text-decoration:underline">&#47;s&#47; Edmund M. Fay&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%"><br>Name&#58;&#160;&#160;&#160;&#160;Edmund M. Fay Title&#58;&#160;&#160;&#160;&#160;Authorized Signatory</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Signature Page to Supplemental Indenture&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A&#38;B Home Health Solutions, LLC </font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">AHM Texas GP, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Apex Hospice LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Camellia Home Health of Alabama, LLC </font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Camellia Home Health of East Tennessee, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Camellia Home Health of the Gulf Coast, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Camellia Hospice of Central Mississippi, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Camellia Hospice of East Louisiana, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Camellia Hospice of Louisiana, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Camellia Hospice of North Mississippi, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Camellia Hospice of Northeast Alabama LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Camellia Hospice of Northeast Mississippi, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Camellia Hospice of South Alabama, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Camellia Hospice of Southwest Mississippi, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Camellia Hospice of the Gulf Coast, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CareServices of the Treasure Coast, LLC </font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CareSouth HHA Holdings of Columbus, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CareSouth HHA Holdings of Dothan, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CareSouth HHA Holdings of Gainesville, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CareSouth HHA Holdings of Greensboro, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CareSouth HHA Holdings of Lexington, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CareSouth HHA Holdings of North Florida, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CareSouth HHA Holdings of Panama City, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CareSouth HHA Holdings of Richmond, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CareSouth HHA Holdings of South Carolina, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CareSouth HHA Holdings of Tallahassee, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CareSouth HHA Holdings of the Bay Area, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CareSouth HHA Holdings of Valley, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CareSouth HHA Holdings of Virginia, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CareSouth HHA Holdings of Washington, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CareSouth HHA Holdings of Western Carolina, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CareSouth HHA Holdings of Winchester, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CareSouth HHA Holdings, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CareSouth Hospice, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Continental Home Care, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Continental Medical Systems, LLC </font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CS Health &#38; Wellness, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Day-By-Day Staff Relief, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Acquisition Holdings, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Acquisition Holdings Subsidiary, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Alabama Real Estate, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Arizona Real Estate, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Arkansas Real Estate, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Boise Holdings, LLC </font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Bryan Holdings, LLC </font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health California Real Estate, LLC</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Signature Page to Supplemental Indenture&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Colorado Real Estate, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Charleston Holdings, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Dayton Holdings, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Deaconess Holdings, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Fairlawn Holdings, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health GKBJH Holdings, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Gulfport Holdings, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Iowa City Holdings, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EH Health Home Health of Alabama, LLC, formerly known as Encompass Health Home Health of Alabama, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EH Health Home Health of Birmingham, LLC, formerly known as Encompass Health Home Health of Birmingham, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EH Health Home Health of Central Virginia, LLC, formerly known as Encompass Health Home Health of Central Virginia, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EH Health Home Health of Florida, LLC, formerly known as Encompass Health Home Health of Florida, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EH Health Home Health of Kentucky, LLC, formerly known as Encompass Health Home Health of Kentucky, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EH Health Home Health of New England, LLC, formerly known as Encompass Health Home Health of New England, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EH Health Home Health of Ohio, LLC, formerly known as Encompass Health Home Health of Ohio, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EH Health Home Health of the Northwest, LLC, formerly known as Encompass Health Home Health of the Northwest, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EH Health Home Health of the Southwest, LLC, formerly known as Encompass Health Home Health of the Southwest, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EH Health Hospice of Alabama, LLC, formerly known as Encompass Health Hospice of Alabama, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EH Health Hospice of Pennsylvania, LLC, formerly known as Encompass Health Hospice of Pennsylvania, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EH Health Hospice of the Midwest, LLC, formerly known as Encompass Health Hospice of the Midwest, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EH Health Hospice of the Northwest, LLC, formerly known as Encompass Health Hospice of the Northwest, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EH Health Hospice of the Southwest, LLC, formerly known as Encompass Health Hospice of the Southwest, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EH Health Ventures Bozeman, LLC, formerly known as Encompass Health HHH Ventures Bozeman, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EH Health Ventures Salida, LLC, formerly known as Encompass Health HHH Ventures Salida, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Iowa Real Estate, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Johnson City Holdings, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Joint Ventures Holdings, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Kansas Real Estate, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Kentucky Real Estate, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Kingsport Holdings, LLC</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Signature Page to Supplemental Indenture&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Littleton Holdings, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Louisiana Real Estate, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Lubbock Holdings, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Martin County Holdings, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Maryland Real Estate, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Massachusetts Real Estate, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Midland Odessa Holdings, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Myrtle Beach Holdings, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Nevada Real Estate, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health New Mexico Real Estate, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Ohio Real Estate, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Owned Hospitals Holdings, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Pennsylvania Real Estate, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Properties, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Real Estate, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Abilene, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Albuquerque, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Altamonte Springs, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Arlington, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Austin, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Bakersfield, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Bluffton, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Braintree, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Cardinal Hill, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Cincinnati, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Cypress, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Dallas, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Desert Canyon, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of East Valley, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Erie, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Fort Smith, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Franklin, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Fredericksburg, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Gadsden, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Greenville, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Harmarville, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Henderson, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Humble, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Katy, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Lakeview, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Largo, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Las Vegas, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Littleton, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Mechanicsburg, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Miami, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Middletown, LLC</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Signature Page to Supplemental Indenture&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Modesto, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Murrieta, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of New England, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of North Tampa, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Northern Kentucky, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Northern Virginia, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Ocala, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Pearland, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Pensacola, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Petersburg, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Plano, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Reading, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Richardson, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Round Rock, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Sarasota, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Scottsdale, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Shelby County, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Shreveport, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Sioux Falls, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Sugar Land, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Sunrise, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Tallahassee, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of the Mid-Cities, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Toledo, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Toms River, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Utah, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Vineland, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Waco, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of Western Massachusetts, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital of York, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital The Vintage, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Hospital Vision Park, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Rehabilitation Institute of Tucson, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health San Angelo Holdings, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Savannah Holdings, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Sea Pines Holdings, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Sewickley Holdings, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health South Carolina Real Estate, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health South Dakota Real Estate, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Support Companies, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Texas Real Estate, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Tucson Holdings, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Tulsa Holdings, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Utah Real Estate, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health ValleyofTheSun Rehabilitation Hospital, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Virginia Real Estate, LLC</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Signature Page to Supplemental Indenture&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Walton Rehabilitation Hospital, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health West Tennessee Holdings, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health West Virginia Real Estate, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Westerville Holdings, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Encompass Health Winston-Salem Holdings, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EH Home Health of Austin, LLC, formerly known as Encompass Home Health of Austin, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EH Home Health of Colorado, LLC, formerly known as Encompass Home Health of Colorado, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EH Home Health of DFW, LLC, formerly known as Encompass Home Health of DFW, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EH Home Health of East Texas, LLC, formerly known as Encompass Home Health of East Texas, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EH Home Health of New England, LLC, formerly known as Encompass Home Health of New England, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EH Home Health of the Mid Atlantic, LLC, formerly known as Encompass Home Health of the Mid Atlantic, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EH Home Health of the Midwest, LLC, formerly known as Encompass Home Health of the Midwest, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EH Home Health of the Southeast, LLC, formerly known as Encompass Home Health of the Southeast, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EH Home Health of the West, LLC, formerly known as Encompass Home Health of the West, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EH Hospice of the West, LLC, formerly known as Encompass Hospice of the West, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EXCELLA ASSOCIATES, L.L.C. </font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EXCELLA HOME HEALTH AGENCY, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">HealthCare Innovations of Oklahoma, L.L.C.</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">HEALTHCARE INNOVATIONS OF WESTERN OKLAHOMA, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">HealthCare Innovations-Travertine Health Services, L.L.C.</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">HealthSouth Rehabilitation Hospital of Forsyth County, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">HealthSouth Rehabilitation Hospital of Fort Worth, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Hospice Care of Mississippi, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Orion Homecare, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Print Promotions Group, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Rebound, LLC</font></div><div style="margin-bottom:2pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Rehabilitation Hospital Corporation of America, LLC</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Signature Page to Supplemental Indenture&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Rehabilitation Hospital of North Alabama, LLC</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Rehabilitation Hospital of Plano, LLC</font></div><div style="padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Saad Healthcare of St. Clair County LLC</font></div><div style="margin-bottom:24pt;padding-left:121.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">TH of San Antonio LLC</font></div><div style="margin-bottom:24pt;padding-left:121.5pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:121.65pt;text-indent:-27.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Edmund M. Fay&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br>Name&#58;&#160;&#160;&#160;&#160;Edmund M. Fay </font></div><div style="padding-left:121.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;  Authorized Signatory</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Signature Page to Supplemental Indenture&#93;</font></div></div></div><div id="i3690ae8cd69747be84944aa2f50dc96c_13"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;padding-left:225.35pt;text-indent:-27.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee</font></div><div style="margin-bottom:24pt;padding-left:225.35pt;text-indent:-27.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58; Computershare Trust Company, National Association, as attorney-in-fact</font></div><div style="padding-left:225.35pt;text-indent:-27.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;  &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Scott R. Little &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br>Name&#58;&#160;&#160;&#160;&#160; Scott Little</font></div><div style="padding-left:225.35pt;text-indent:-27.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Title&#58;&#160;&#160;&#160;&#160;Vice President</font></div><div style="margin-bottom:24pt;padding-left:225pt;text-indent:-27pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Signature Page to Supplemental Indenture&#93;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>ehc-20220124.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9183fd02-6ba0-427e-aed8-2afb8feef5c2,g:4e4b24bf-85db-4e7c-8d21-1420c27e3951-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ehc="http://www.encompasshealth.com/20220124" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.encompasshealth.com/20220124">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehc-20220124_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehc-20220124_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformationDocumentandEntityInformation" roleURI="http://www.encompasshealth.com/role/DocumentandEntityInformationDocumentandEntityInformation">
        <link:definition>0001001 - Document - Document and Entity Information Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>ehc-20220124_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9183fd02-6ba0-427e-aed8-2afb8feef5c2,g:4e4b24bf-85db-4e7c-8d21-1420c27e3951-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityAddressAddressLine1_bdc2c6a3-d9f1-448f-a752-1238ea85d293_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_ce5aa87b-95b1-48e2-bb4c-b15021c347d6_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_e391f9fb-9f2d-426c-aaf6-40877ee10b76_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_81946240-e7cc-44a2-97ca-fc08ea5d499d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_d5a35fd6-1777-426b-ba2d-98ff834d00b0_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_a0b74c3d-dc81-494e-8a63-a6f55c65a61b_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_4e706f3a-789e-414b-a216-e4797c300951_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_62be2ec2-4fe3-46ac-962f-49e1ab3f339d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_2a1548e7-252d-4055-9ca0-afe87d219169_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_c65b9914-6c86-4f1a-8469-691c0384f7e8_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_60a272ce-29ec-4721-a90a-490a1c55679d_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_f1e570b3-bc28-4595-ad66-ee6c5f5b5af5_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_13948111-f321-4c74-bbc2-1356e589fa9f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_07ac37ca-43ac-446e-8897-4e8a9579e326_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_ac345452-d04d-441a-a59f-9364f02de64b_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_89070fd7-4d37-45fa-b92c-1cfdffe2877c_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_174a7c22-34a7-426b-9f10-133a11cd410d_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_a5f32288-84fb-4b83-9e17-b10ddb1629b2_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_20909b79-c4d0-4d01-87f7-3253eba8b97f_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_a8f91203-a0d7-4533-ac0b-b6c1c85ee2e7_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_1be51019-c14d-4345-81bf-6eee36e1d883_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_44947e1b-9652-4df6-98a5-26f05b00b87f_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_7f8f80da-1cdc-4372-8fa6-6af8db1b09c6_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>ehc-20220124_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9183fd02-6ba0-427e-aed8-2afb8feef5c2,g:4e4b24bf-85db-4e7c-8d21-1420c27e3951-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.encompasshealth.com/role/DocumentandEntityInformationDocumentandEntityInformation" xlink:type="simple" xlink:href="ehc-20220124.xsd#DocumentandEntityInformationDocumentandEntityInformation"/>
  <link:presentationLink xlink:role="http://www.encompasshealth.com/role/DocumentandEntityInformationDocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_e51c8a16-d0aa-42e6-a81c-43952e0332a9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_e0e8d413-6d53-43f9-b770-aa74d15ed5a9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e51c8a16-d0aa-42e6-a81c-43952e0332a9" xlink:to="loc_dei_DocumentType_e0e8d413-6d53-43f9-b770-aa74d15ed5a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_ee805f4f-f337-455b-b421-d63a6e5aebdc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e51c8a16-d0aa-42e6-a81c-43952e0332a9" xlink:to="loc_dei_DocumentPeriodEndDate_ee805f4f-f337-455b-b421-d63a6e5aebdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e0169291-2fc4-4c20-a1ff-a4deaf160673" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e51c8a16-d0aa-42e6-a81c-43952e0332a9" xlink:to="loc_dei_EntityRegistrantName_e0169291-2fc4-4c20-a1ff-a4deaf160673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_324d70e1-e0ed-43ef-8d50-6926197094fa" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e51c8a16-d0aa-42e6-a81c-43952e0332a9" xlink:to="loc_dei_EntityIncorporationStateCountryCode_324d70e1-e0ed-43ef-8d50-6926197094fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_4a6aba94-0190-4b53-873a-8afbba826d12" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e51c8a16-d0aa-42e6-a81c-43952e0332a9" xlink:to="loc_dei_EntityFileNumber_4a6aba94-0190-4b53-873a-8afbba826d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_09eb94a9-66d6-4eeb-b332-fe55e72a3691" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e51c8a16-d0aa-42e6-a81c-43952e0332a9" xlink:to="loc_dei_EntityTaxIdentificationNumber_09eb94a9-66d6-4eeb-b332-fe55e72a3691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_c259fa66-5279-4cb8-972f-63fe5a3ba1ec" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e51c8a16-d0aa-42e6-a81c-43952e0332a9" xlink:to="loc_dei_EntityAddressAddressLine1_c259fa66-5279-4cb8-972f-63fe5a3ba1ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_abb11295-27ec-4f15-8536-bf9406f0fc23" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e51c8a16-d0aa-42e6-a81c-43952e0332a9" xlink:to="loc_dei_EntityAddressCityOrTown_abb11295-27ec-4f15-8536-bf9406f0fc23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_a5aa51ec-b66a-40fd-94ba-c41e6da06f6c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e51c8a16-d0aa-42e6-a81c-43952e0332a9" xlink:to="loc_dei_EntityAddressStateOrProvince_a5aa51ec-b66a-40fd-94ba-c41e6da06f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_94801894-9e26-4e93-a942-60c963973707" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e51c8a16-d0aa-42e6-a81c-43952e0332a9" xlink:to="loc_dei_EntityAddressPostalZipCode_94801894-9e26-4e93-a942-60c963973707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_609c37d0-ecda-419b-9fc6-54c82e7b4707" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e51c8a16-d0aa-42e6-a81c-43952e0332a9" xlink:to="loc_dei_CityAreaCode_609c37d0-ecda-419b-9fc6-54c82e7b4707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_53292197-02f3-4ddd-af6f-88dcda63bc5c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e51c8a16-d0aa-42e6-a81c-43952e0332a9" xlink:to="loc_dei_LocalPhoneNumber_53292197-02f3-4ddd-af6f-88dcda63bc5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_3a57e685-bc37-4b83-93f5-177c3040f465" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e51c8a16-d0aa-42e6-a81c-43952e0332a9" xlink:to="loc_dei_WrittenCommunications_3a57e685-bc37-4b83-93f5-177c3040f465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_d2781528-3ebf-4209-a562-149c824affb6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e51c8a16-d0aa-42e6-a81c-43952e0332a9" xlink:to="loc_dei_SolicitingMaterial_d2781528-3ebf-4209-a562-149c824affb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_7062b867-ecc9-4b37-9a7a-b4109b20e596" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e51c8a16-d0aa-42e6-a81c-43952e0332a9" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_7062b867-ecc9-4b37-9a7a-b4109b20e596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_f04e0a3d-de9e-40e6-8843-dc743d8192f6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e51c8a16-d0aa-42e6-a81c-43952e0332a9" xlink:to="loc_dei_PreCommencementTenderOffer_f04e0a3d-de9e-40e6-8843-dc743d8192f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ecfae311-60e4-49ab-ba4c-eaf01573543b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e51c8a16-d0aa-42e6-a81c-43952e0332a9" xlink:to="loc_dei_EntityEmergingGrowthCompany_ecfae311-60e4-49ab-ba4c-eaf01573543b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_cec43d79-936e-4a21-b272-bbec24fb1f2c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e51c8a16-d0aa-42e6-a81c-43952e0332a9" xlink:to="loc_dei_Security12bTitle_cec43d79-936e-4a21-b272-bbec24fb1f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_2b1035fe-5963-4d97-b4ae-72fc379b904b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e51c8a16-d0aa-42e6-a81c-43952e0332a9" xlink:to="loc_dei_TradingSymbol_2b1035fe-5963-4d97-b4ae-72fc379b904b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_67d06a3c-54cd-4536-846e-68cd75401ae5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e51c8a16-d0aa-42e6-a81c-43952e0332a9" xlink:to="loc_dei_SecurityExchangeName_67d06a3c-54cd-4536-846e-68cd75401ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_c001c5f6-b439-4d80-9138-e1db4e723015" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e51c8a16-d0aa-42e6-a81c-43952e0332a9" xlink:to="loc_dei_AmendmentFlag_c001c5f6-b439-4d80-9138-e1db4e723015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_7d7603c5-9233-4c32-aed9-27e6d82fadc3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e51c8a16-d0aa-42e6-a81c-43952e0332a9" xlink:to="loc_dei_EntityCentralIndexKey_7d7603c5-9233-4c32-aed9-27e6d82fadc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140144222977976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jan. 24, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 24,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Encompass Health Corporation<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-10315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">63-0860407<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9001 Liberty Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Birmingham<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">AL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">35242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">967-7116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EHC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000785161<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>ehc-20220124_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ehc-20220124.xsd" xlink:type="simple"/>
    <context id="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000785161</identifier>
        </entity>
        <period>
            <startDate>2022-01-24</startDate>
            <endDate>2022-01-24</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124"
      id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF80L2ZyYWc6MWM0NjAyYzFhZmJlNDgzNDgzNTk5YjAyNWI1M2IyZmEvdGFibGU6NDJlYTFjYjBjZmIzNDQzZTgxNGE0NTYzMzUwYzUxNTYvdGFibGVyYW5nZTo0MmVhMWNiMGNmYjM0NDNlODE0YTQ1NjMzNTBjNTE1Nl8wLTEtMS0xLTkwODQw_1049c634-9f10-41ba-b5f3-8b6c676f5646">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124"
      id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF80L2ZyYWc6MWM0NjAyYzFhZmJlNDgzNDgzNTk5YjAyNWI1M2IyZmEvdGFibGU6NDJlYTFjYjBjZmIzNDQzZTgxNGE0NTYzMzUwYzUxNTYvdGFibGVyYW5nZTo0MmVhMWNiMGNmYjM0NDNlODE0YTQ1NjMzNTBjNTE1Nl8xLTEtMS0xLTkwODQw_b7856ed8-ea9d-4ad2-939e-939bec232984">0000785161</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124"
      id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGV4dHJlZ2lvbjpkNjk3NGMwOGM2NzE0YjE2YjI5OGEzZmE2MmY0MjFhYl8xMjY5_87a180c8-9a77-4510-8ce0-438d8c70fafc">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124"
      id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGV4dHJlZ2lvbjpkNjk3NGMwOGM2NzE0YjE2YjI5OGEzZmE2MmY0MjFhYl8yMjU_7b34d820-4cd2-4794-a7a4-8d342db3637c">2022-01-24</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124"
      id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGV4dHJlZ2lvbjpkNjk3NGMwOGM2NzE0YjE2YjI5OGEzZmE2MmY0MjFhYl8xMjcw_c285b0a4-dc7b-4943-8c2e-72cd89276fbd">Encompass Health Corporation</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124"
      id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGV4dHJlZ2lvbjpkNjk3NGMwOGM2NzE0YjE2YjI5OGEzZmE2MmY0MjFhYl8xMjYy_376ca7a9-7bc8-437e-9c04-1b06c19240b8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124"
      id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGFibGU6Y2E1MGNiOTllNDY1NGE2YWIzMTI2Zjc0ZGU5NTA0MDYvdGFibGVyYW5nZTpjYTUwY2I5OWU0NjU0YTZhYjMxMjZmNzRkZTk1MDQwNl8wLTAtMS0xLTkwODQw_f92f4f4d-04b5-4bc0-95fb-ceed39c207a9">001-10315</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124"
      id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGFibGU6Y2E1MGNiOTllNDY1NGE2YWIzMTI2Zjc0ZGU5NTA0MDYvdGFibGVyYW5nZTpjYTUwY2I5OWU0NjU0YTZhYjMxMjZmNzRkZTk1MDQwNl8wLTEtMS0xLTkwODQw_bf2a08a6-3441-4aeb-84b6-dea2823b213b">63-0860407</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124"
      id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGV4dHJlZ2lvbjpkNjk3NGMwOGM2NzE0YjE2YjI5OGEzZmE2MmY0MjFhYl8xMjYz_4834072c-09c8-4b25-b935-b77d27091091">9001 Liberty Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124"
      id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGV4dHJlZ2lvbjpkNjk3NGMwOGM2NzE0YjE2YjI5OGEzZmE2MmY0MjFhYl8xMjY0_14199743-68c2-446e-aeea-e262afc8394d">Birmingham</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124"
      id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGV4dHJlZ2lvbjpkNjk3NGMwOGM2NzE0YjE2YjI5OGEzZmE2MmY0MjFhYl8xMjY1_c379699f-4607-46c9-bdb7-7b240f6450bf">AL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124"
      id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGV4dHJlZ2lvbjpkNjk3NGMwOGM2NzE0YjE2YjI5OGEzZmE2MmY0MjFhYl8xMjY2_b17fb179-daea-4f44-8311-96371c305377">35242</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124"
      id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGV4dHJlZ2lvbjpkNjk3NGMwOGM2NzE0YjE2YjI5OGEzZmE2MmY0MjFhYl8xMjYx_ea0ff63c-45a9-4a27-825f-c8f537fbf8fe">205</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124"
      id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGV4dHJlZ2lvbjpkNjk3NGMwOGM2NzE0YjE2YjI5OGEzZmE2MmY0MjFhYl8xMjY3_7cb1dd31-30ef-4be2-af07-05dded433c34">967-7116</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124"
      id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGFibGU6OGUyNWIwOGEzMjRkNGNmZDk4OTk4YjNmNThhZTE3N2MvdGFibGVyYW5nZTo4ZTI1YjA4YTMyNGQ0Y2ZkOTg5OThiM2Y1OGFlMTc3Y18wLTAtMS0xLTkwODQw_213f5900-577b-4a87-a3dd-3964d5b441c1">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124"
      id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGFibGU6OGUyNWIwOGEzMjRkNGNmZDk4OTk4YjNmNThhZTE3N2MvdGFibGVyYW5nZTo4ZTI1YjA4YTMyNGQ0Y2ZkOTg5OThiM2Y1OGFlMTc3Y18yLTAtMS0xLTkwODQw_42bea57f-c82d-4c08-8e69-a436ee5b1f9b">false</dei:SolicitingMaterial>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124"
      id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGFibGU6OGUyNWIwOGEzMjRkNGNmZDk4OTk4YjNmNThhZTE3N2MvdGFibGVyYW5nZTo4ZTI1YjA4YTMyNGQ0Y2ZkOTg5OThiM2Y1OGFlMTc3Y180LTAtMS0xLTkwODQw_ec40354d-8e94-43c5-9c1b-a4e9a12fce49">false</dei:PreCommencementIssuerTenderOffer>
    <dei:PreCommencementTenderOffer
      contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124"
      id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGFibGU6OGUyNWIwOGEzMjRkNGNmZDk4OTk4YjNmNThhZTE3N2MvdGFibGVyYW5nZTo4ZTI1YjA4YTMyNGQ0Y2ZkOTg5OThiM2Y1OGFlMTc3Y182LTAtMS0xLTkwODQw_844919c4-baa3-401f-91ee-4f47fd6df5dc">false</dei:PreCommencementTenderOffer>
    <dei:EntityEmergingGrowthCompany
      contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124"
      id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGV4dHJlZ2lvbjpkNjk3NGMwOGM2NzE0YjE2YjI5OGEzZmE2MmY0MjFhYl8xMjY4_def96faa-9f21-4021-be1b-100847cbeeaa">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle
      contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124"
      id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGFibGU6YTc5NzRmMGFkZmE2NDQzOWE3OTAxOWE3NWUzMzJkYzIvdGFibGVyYW5nZTphNzk3NGYwYWRmYTY0NDM5YTc5MDE5YTc1ZTMzMmRjMl8xLTAtMS0xLTkwODQw_06b607d7-cf65-4207-bfbe-d38663a8fe94">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124"
      id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGFibGU6YTc5NzRmMGFkZmE2NDQzOWE3OTAxOWE3NWUzMzJkYzIvdGFibGVyYW5nZTphNzk3NGYwYWRmYTY0NDM5YTc5MDE5YTc1ZTMzMmRjMl8xLTEtMS0xLTkwODQw_de61cfdb-4743-4091-8a33-2cfa7878c348">EHC</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i28e0025b933a49418a8c83965192b0c0_D20220124-20220124"
      id="id3VybDovL2RvY3MudjEvZG9jOjExN2RkNzJjODk0ODQ2Zjc5NDhhZWJhZDk0MmE1NGZkL3NlYzoxMTdkZDcyYzg5NDg0NmY3OTQ4YWViYWQ5NDJhNTRmZF8xL2ZyYWc6ZDY5NzRjMDhjNjcxNGIxNmIyOThhM2ZhNjJmNDIxYWIvdGFibGU6YTc5NzRmMGFkZmE2NDQzOWE3OTAxOWE3NWUzMzJkYzIvdGFibGVyYW5nZTphNzk3NGYwYWRmYTY0NDM5YTc5MDE5YTc1ZTMzMmRjMl8xLTItMS0xLTkwODQw_a4e94e3b-cd9d-465f-b930-89389ac01f5c">NYSE</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M> \^>Q\ETWLJ.?]74_P$4$L#!!0    ( %2).527BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ 5(DY5!PX9>H_ 0
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M 5!+ 0(4 Q0    ( %2).50'04UB@0   +$    0              "  0
M  !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ 5(DY5*M+3/SN    *P(
M !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%
M  @ 5(DY5)E<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE
M+W1H96UE,2YX;6Q02P$"% ,4    " !4B3E438^YR#L$  !Q$   &
M        @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%
M  @ 5(DY5)^@&_"Q @  X@P   T              ( !?@P  'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    " !4B3E4EXJ[',     3 @  "P
M@ %:#P  7W)E;',O+G)E;'-02P$"% ,4    " !4B3E4'#AEZC\!   \ @
M#P              @ %#$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
M5(DY5"0>FZ*M    ^ $  !H              ( !KQ$  'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ 5(DY5&60>9(9 0  SP,  !,
M             ( !E!(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D
,"0 ^ @  WA,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>122</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ehc-20220124.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Document and Entity Information Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.encompasshealth.com/role/DocumentandEntityInformationDocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ehc-20220124.htm">ehc-20220124.htm</File>
    <File>ehc-20220124.xsd</File>
    <File>ehc-20220124_lab.xml</File>
    <File>ehc-20220124_pre.xml</File>
    <File>twelfthsupplementalindeture.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ehc-20220124.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "ehc-20220124.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ehc-20220124_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ehc-20220124_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ehc-20220124.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 122,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ehc",
   "nsuri": "http://www.encompasshealth.com/20220124",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehc-20220124.htm",
      "contextRef": "i28e0025b933a49418a8c83965192b0c0_D20220124-20220124",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Document and Entity Information Document and Entity Information",
     "role": "http://www.encompasshealth.com/role/DocumentandEntityInformationDocumentandEntityInformation",
     "shortName": "Document and Entity Information Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehc-20220124.htm",
      "contextRef": "i28e0025b933a49418a8c83965192b0c0_D20220124-20220124",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentandEntityInformationDocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentandEntityInformationDocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentandEntityInformationDocumentandEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentandEntityInformationDocumentandEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentandEntityInformationDocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentandEntityInformationDocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentandEntityInformationDocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentandEntityInformationDocumentandEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentandEntityInformationDocumentandEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentandEntityInformationDocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentandEntityInformationDocumentandEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentandEntityInformationDocumentandEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentandEntityInformationDocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentandEntityInformationDocumentandEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentandEntityInformationDocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentandEntityInformationDocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentandEntityInformationDocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentandEntityInformationDocumentandEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentandEntityInformationDocumentandEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentandEntityInformationDocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentandEntityInformationDocumentandEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentandEntityInformationDocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0000785161-22-000003-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000785161-22-000003-xbrl.zip
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MB,H3-9L%:M9%9?*HB]P?8=QEF=F+W$D9\_SP)[XP_!WZ 8/6;1"_MPAEZ29
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M-=,%NLU W:-<B@K="GG/'@G&"P<Z$_639*M"HRB(HGVM3&;A=))G082_I"3
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M(/O)%^Z\WX,.W)F\ :2DI$UY.&X;UJNP3MCWN-L _G %M/>=->$$[?Y9C/X
M4$L#!!0    ( %2).51.*3@*:PH  *5>   4    96AC+3(P,C(P,3(T7VQA
M8BYX;6S5G&%OV[H5AK_W5VC9EPVXK$6*DLBBS467VP[%<MNB2=&+#8-!4F0B
MU)%R9:5)_OTHV4XL6[))RE:U+XGCT(?O>>WG\(@1\_K7AYN9]T,6\S3/WIS
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M')E0&SNL$.W.VAG2EI"#8=J=SCJH.T;UW-"Z*'7 3\7G(O^1:K'3"'&)I$
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M==Q:?^^.V]/-?K_IE7,:^0S%2$B J!0 QP@"1GVF^UV?01&&46S>[[;.,%H
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M'3O7CTY?K)Y)%__7_/3%_P!02P,$%     @ 5(DY5"WJXY.]!@  WC$  !0
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M=V/=[GQBNA\)$^Y2#A=T-"+>+)Z)>(X'3@X>OFC_M/\0<'+P7U!+ P04
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M5*H[(S (DWR0!;'E!7U/FI*[4A#KXV=ZD0PS'!,V%*[P'12!G..V&X(R85]
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MJ6$!I5S'E@;KTB$NH.6Z7<,L%3CB$U6?H_<^.K5L!Z.^JI4W$B!6E$:$3U6
M_TGJ;C;H4DE@+6Y5&(ZKU*?:XSO5I5%]?V)3A9=3IQ_M-WH@'PL6J^+B4?L
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M+3(P,C(P,3(T+GAS9%!+ 0(4 Q0    ( %2).51.*3@*:PH  *5>   4
M          "  2X=  !E:&,M,C R,C Q,C1?;&%B+GAM;%!+ 0(4 Q0    (
M %2).50MZN.3O08  -XQ   4              "  <LG  !E:&,M,C R,C Q
M,C1?<')E+GAM;%!+ 0(4 Q0    ( %2).52+3*Q2SS$  -MT @ ?
M      "  ;HN  !T=V5L9G1H<W5P<&QE;65N=&%L:6YD971U<F4N:'1M4$L%
3!@     %  4 30$  ,9@      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
